Guardant Health Inc at Cowen Health Care Conference (Virtual) Transcript
Hi, everybody. Thank you for being here. I'm Max Masucci from Cowen's Life Science Diagnostic Tools Research team. We are pleased to be joined by Guardant Health, the liquid biopsy market leader and a key player across blood-based applications for therapy selection, MRD monitoring and noninvasive screening.
We're joined today by co-CEO, AmirAli Talasaz; and CFO, Mike Bell. Gentlemen, thanks for being here.
Yes, thanks you for having us.
Questions & Answers
Great. All right. So let's start right in. We had an MRD monitoring panel yesterday morning. We had a screening panel in the afternoon. I'm not going to ask you to predict the final sensitivity number in the ECLIPSE trial. But if we take into consideration a few things. Number 1, the quality and availability of biobank samples you used in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
